trimethyloxamine has been researched along with hematoxylin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Hong, Q; Huang, G; Que, D; Yan, J; Yang, P; Zhai, W; Zhong, C | 1 |
1 other study(ies) available for trimethyloxamine and hematoxylin
| Article | Year |
|---|---|
Trimethylamine-N-oxide (TMAO) promotes balloon injury-induced neointimal hyperplasia via upregulating Beclin1 and impairing autophagic flux.
Topics: Animals; Anti-Bacterial Agents; Beclin-1; Carotid Artery Injuries; Cell Proliferation; Endothelial Cells; Eosine Yellowish-(YS); Hematoxylin; Hyperplasia; Muscle, Smooth, Vascular; Neointima; Oxides; Rats; Rats, Sprague-Dawley | 2022 |